Factor XIII A-Subunit (Recombinant) and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Factor XIII A-Subunit (Recombinant) and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: factor XIII
Brand name: Corifact, Tretten
Synonyms: Factor XIII
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor XIII A-Subunit (Recombinant)-Kitabis Pak
- Factor XIII A-Subunit (Recombinant)-Kitabis Pak inhalation
- Factor XIII A-Subunit (Recombinant)-Klofensaid II
- Factor XIII A-Subunit (Recombinant)-Klonopin
- Factor XIII A-Subunit (Recombinant)-Klonopin Wafer
- Factor XIII A-Subunit (Recombinant)-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Factor XIII Concentrate (Human)
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Factor xiii Intravenous
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Factrel
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-FaLessa
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-FaLessa Kit
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Fallback Solo